バイオテクノロジーおよび医薬品におけるナノ粒子の世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2023)

【英語タイトル】Global Nanoparticles in Biotechnology and Pharmaceuticals Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

GlobalInfoResearchが出版した調査資料(GIR8104396)・商品コード:GIR8104396
・発行会社(調査会社):GlobalInfoResearch
・発行日:2018年8月30日
・ページ数:149
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:世界
・産業分野:医療・バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,030,080見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートは、バイオテクノロジーおよび医薬品におけるナノ粒子の世界市場について調べ、まとめました。種類別セグメントは、フラーレン類、液晶、リポソーム、ナノシェル、量子ドット、その他等、用途別セグメントは、バイオテクノロジー、医薬品等に区分しました。バイオテクノロジーおよび医薬品におけるナノ粒子の世界市場概観、メーカー動向、メーカー別バイオテクノロジーおよび医薬品におけるナノ粒子シェア、市場規模推移、市場規模予測、主要地域分析(北米、ヨーロッパ、アジア等)、主要国分析(日本、中国、アメリカ等)データなどの情報が含まれています。
・バイオテクノロジーおよび医薬品におけるナノ粒子の市場概観
・バイオテクノロジーおよび医薬品におけるナノ粒子のメーカー概要(事業概要、製品種類、価格、売上、市場シェア等)
・バイオテクノロジーおよび医薬品におけるナノ粒子のメーカー別販売動向、市場シェア、市場集中度、競争動向
・バイオテクノロジーおよび医薬品におけるナノ粒子の世界市場規模
・バイオテクノロジーおよび医薬品におけるナノ粒子の北米市場分析(アメリカ、カナダ、メキシコ等)
・バイオテクノロジーおよび医薬品におけるナノ粒子のアメリカ市場規模推移
・バイオテクノロジーおよび医薬品におけるナノ粒子のカナダ市場規模推移
・バイオテクノロジーおよび医薬品におけるナノ粒子のメキシコ市場規模推移
・バイオテクノロジーおよび医薬品におけるナノ粒子のヨーロッパ市場分析(ドイツ、イギリス、ロシア、フランス、イタリア等)
・バイオテクノロジーおよび医薬品におけるナノ粒子のドイツ市場規模推移
・バイオテクノロジーおよび医薬品におけるナノ粒子のイギリス市場規模推移
・バイオテクノロジーおよび医薬品におけるナノ粒子のロシア市場規模推移
・バイオテクノロジーおよび医薬品におけるナノ粒子のアジア市場分析(日本、中国、韓国、インド、東南アジア等)
・バイオテクノロジーおよび医薬品におけるナノ粒子の日本市場規模推移
・バイオテクノロジーおよび医薬品におけるナノ粒子の中国市場規模推移
・バイオテクノロジーおよび医薬品におけるナノ粒子の韓国市場規模推移
・バイオテクノロジーおよび医薬品におけるナノ粒子のインド市場規模推移
・バイオテクノロジーおよび医薬品におけるナノ粒子の東南アジア市場規模推移
・バイオテクノロジーおよび医薬品におけるナノ粒子の南米市場分析(ブラジル、アルゼンチン等)
・バイオテクノロジーおよび医薬品におけるナノ粒子の中東・アフリカ市場分析(サウジアラビア、UAE、南アフリカ等)
・バイオテクノロジーおよび医薬品におけるナノ粒子の種類別分析/市場規模推移(フラーレン類、液晶、リポソーム、ナノシェル、量子ドット、その他)
・バイオテクノロジーおよび医薬品におけるナノ粒子の用途別分析/市場規模推移(バイオテクノロジー、医薬品)
・バイオテクノロジーおよび医薬品におけるナノ粒子の市場予測(地域別予測、種類別予測、用途別予測)
・バイオテクノロジーおよび医薬品におけるナノ粒子の販売チャネル・代理店・貿易業者・ディーラー分析
【レポートの概要】

Nanoparticles are sub-nanosized colloidal structures composed of synthetic or semi-synthetic polymers. These are used in biotechnology and pharmaceutical sectors for studying biological systems for diagnosing diseases and focusing on treatment at the molecular level. The properties of many conventional materials alter when formed from nanoparticles, the reason being nanoparticles have a greater surface area per weight than larger particles, making them more reactive to other molecules

Scope of the Report:

This report focuses on the Nanoparticles in Biotechnology and Pharmaceuticals in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The nanoparticle segment of the nanotechnology has wider application in pharmaceuticals such as in drug delivery and drug discovery, and in biotechnology such as in studying cellular dynamics and stem cell research. Nanotechnology is growing steadily supported by governments and technology firms making high investments in developing nanotechnology.

Sedentary lifestyles and unbalanced diets, supported by the growing rate of urbanization, are consequent in increased widespread prevalence of chronic diseases. Chronic and lifestyle diseases such as cancer, heart diseases, stroke, chronic respiratory diseases, and diabetes. Nanoparticles are utilized to determine the biological alterations of peptide and protein fragments. This diagnosis aids in developing new treatment solutions to treat the growing incidences of chronic diseases. The increasing prevalence of chronic diseases is identified to be one of the key trends having a positive impact on the nanoparticles market in biotechnology and pharmaceutical sectors.

The worldwide market for Nanoparticles in Biotechnology and Pharmaceuticals is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

Roche

GE Healthcare

Merck

Novartis

AMAG Pharmaceuticals

Amgen

Bausch & Lomb

Biogen

Celgene

Gilead

Ipsen

Leadiant Biosciences

nanoComposix

Pacira Pharmaceuticals

Pfizer

Shire

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Fullerenes

Liquid Crystals

Liposomes

Nanoshells

Quantum dots

Superparamagnetic nanoparticles

Market Segment by Applications, can be divided into

Biotechnology

Pharmaceutical

There are 15 Chapters to deeply display the global Nanoparticles in Biotechnology and Pharmaceuticals market.

Chapter 1, to describe Nanoparticles in Biotechnology and Pharmaceuticals Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Nanoparticles in Biotechnology and Pharmaceuticals, with sales, revenue, and price of Nanoparticles in Biotechnology and Pharmaceuticals, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Nanoparticles in Biotechnology and Pharmaceuticals, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Nanoparticles in Biotechnology and Pharmaceuticals market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Nanoparticles in Biotechnology and Pharmaceuticals sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

【レポートの目次】

Table of Contents

1 Market Overview

1.1 Nanoparticles in Biotechnology and Pharmaceuticals Introduction

1.2 Market Analysis by Type

1.2.1 Fullerenes

1.2.2 Liquid Crystals

1.2.3 Liposomes

1.2.4 Nanoshells

1.2.5 Quantum dots

1.2.6 Superparamagnetic nanoparticles

1.3 Market Analysis by Applications

1.3.1 Biotechnology

1.3.2 Pharmaceutical

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Roche

2.1.1 Business Overview

2.1.2 Nanoparticles in Biotechnology and Pharmaceuticals Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Roche Nanoparticles in Biotechnology and Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 GE Healthcare

2.2.1 Business Overview

2.2.2 Nanoparticles in Biotechnology and Pharmaceuticals Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 GE Healthcare Nanoparticles in Biotechnology and Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Merck

2.3.1 Business Overview

2.3.2 Nanoparticles in Biotechnology and Pharmaceuticals Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Merck Nanoparticles in Biotechnology and Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Novartis

2.4.1 Business Overview

2.4.2 Nanoparticles in Biotechnology and Pharmaceuticals Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Novartis Nanoparticles in Biotechnology and Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 AMAG Pharmaceuticals

2.5.1 Business Overview

2.5.2 Nanoparticles in Biotechnology and Pharmaceuticals Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 AMAG Pharmaceuticals Nanoparticles in Biotechnology and Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Amgen

2.6.1 Business Overview

2.6.2 Nanoparticles in Biotechnology and Pharmaceuticals Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Amgen Nanoparticles in Biotechnology and Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Bausch & Lomb

2.7.1 Business Overview

2.7.2 Nanoparticles in Biotechnology and Pharmaceuticals Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Bausch & Lomb Nanoparticles in Biotechnology and Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 Biogen

2.8.1 Business Overview

2.8.2 Nanoparticles in Biotechnology and Pharmaceuticals Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Biogen Nanoparticles in Biotechnology and Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9 Celgene

2.9.1 Business Overview

2.9.2 Nanoparticles in Biotechnology and Pharmaceuticals Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Celgene Nanoparticles in Biotechnology and Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.10 Gilead

2.10.1 Business Overview

2.10.2 Nanoparticles in Biotechnology and Pharmaceuticals Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Gilead Nanoparticles in Biotechnology and Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.11 Ipsen

2.11.1 Business Overview

2.11.2 Nanoparticles in Biotechnology and Pharmaceuticals Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 Ipsen Nanoparticles in Biotechnology and Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.12 Leadiant Biosciences

2.12.1 Business Overview

2.12.2 Nanoparticles in Biotechnology and Pharmaceuticals Type and Applications

2.12.2.1 Product A

2.12.2.2 Product B

2.12.3 Leadiant Biosciences Nanoparticles in Biotechnology and Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.13 nanoComposix

2.13.1 Business Overview

2.13.2 Nanoparticles in Biotechnology and Pharmaceuticals Type and Applications

2.13.2.1 Product A

2.13.2.2 Product B

2.13.3 nanoComposix Nanoparticles in Biotechnology and Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.14 Pacira Pharmaceuticals

2.14.1 Business Overview

2.14.2 Nanoparticles in Biotechnology and Pharmaceuticals Type and Applications

2.14.2.1 Product A

2.14.2.2 Product B

2.14.3 Pacira Pharmaceuticals Nanoparticles in Biotechnology and Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.15 Pfizer

2.15.1 Business Overview

2.15.2 Nanoparticles in Biotechnology and Pharmaceuticals Type and Applications

2.15.2.1 Product A

2.15.2.2 Product B

2.15.3 Pfizer Nanoparticles in Biotechnology and Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.16 Shire

2.16.1 Business Overview

2.16.2 Nanoparticles in Biotechnology and Pharmaceuticals Type and Applications

2.16.2.1 Product A

2.16.2.2 Product B

2.16.3 Shire Nanoparticles in Biotechnology and Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Nanoparticles in Biotechnology and Pharmaceuticals Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Nanoparticles in Biotechnology and Pharmaceuticals Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Nanoparticles in Biotechnology and Pharmaceuticals Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Nanoparticles in Biotechnology and Pharmaceuticals Manufacturer Market Share in 2017

3.3.2 Top 6 Nanoparticles in Biotechnology and Pharmaceuticals Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Nanoparticles in Biotechnology and Pharmaceuticals Market Analysis by Regions

4.1 Global Nanoparticles in Biotechnology and Pharmaceuticals Sales, Revenue and Market Share by Regions

4.1.1 Global Nanoparticles in Biotechnology and Pharmaceuticals Sales and Market Share by Regions (2013-2018)

4.1.2 Global Nanoparticles in Biotechnology and Pharmaceuticals Revenue and Market Share by Regions (2013-2018)

4.2 North America Nanoparticles in Biotechnology and Pharmaceuticals Sales and Growth Rate (2013-2018)

4.3 Europe Nanoparticles in Biotechnology and Pharmaceuticals Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Nanoparticles in Biotechnology and Pharmaceuticals Sales and Growth Rate (2013-2018)

4.5 South America Nanoparticles in Biotechnology and Pharmaceuticals Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Nanoparticles in Biotechnology and Pharmaceuticals Sales and Growth Rate (2013-2018)

5 North America Nanoparticles in Biotechnology and Pharmaceuticals by Countries

5.1 North America Nanoparticles in Biotechnology and Pharmaceuticals Sales, Revenue and Market Share by Countries

5.1.1 North America Nanoparticles in Biotechnology and Pharmaceuticals Sales and Market Share by Countries (2013-2018)

5.1.2 North America Nanoparticles in Biotechnology and Pharmaceuticals Revenue and Market Share by Countries (2013-2018)

5.2 United States Nanoparticles in Biotechnology and Pharmaceuticals Sales and Growth Rate (2013-2018)

5.3 Canada Nanoparticles in Biotechnology and Pharmaceuticals Sales and Growth Rate (2013-2018)

5.4 Mexico Nanoparticles in Biotechnology and Pharmaceuticals Sales and Growth Rate (2013-2018)

6 Europe Nanoparticles in Biotechnology and Pharmaceuticals by Countries

6.1 Europe Nanoparticles in Biotechnology and Pharmaceuticals Sales, Revenue and Market Share by Countries

6.1.1 Europe Nanoparticles in Biotechnology and Pharmaceuticals Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Nanoparticles in Biotechnology and Pharmaceuticals Revenue and Market Share by Countries (2013-2018)

6.2 Germany Nanoparticles in Biotechnology and Pharmaceuticals Sales and Growth Rate (2013-2018)

6.3 UK Nanoparticles in Biotechnology and Pharmaceuticals Sales and Growth Rate (2013-2018)

6.4 France Nanoparticles in Biotechnology and Pharmaceuticals Sales and Growth Rate (2013-2018)

6.5 Russia Nanoparticles in Biotechnology and Pharmaceuticals Sales and Growth Rate (2013-2018)

6.6 Italy Nanoparticles in Biotechnology and Pharmaceuticals Sales and Growth Rate (2013-2018)

7 Asia-Pacific Nanoparticles in Biotechnology and Pharmaceuticals by Countries

7.1 Asia-Pacific Nanoparticles in Biotechnology and Pharmaceuticals Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Nanoparticles in Biotechnology and Pharmaceuticals Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Nanoparticles in Biotechnology and Pharmaceuticals Revenue and Market Share by Countries (2013-2018)

7.2 China Nanoparticles in Biotechnology and Pharmaceuticals Sales and Growth Rate (2013-2018)

7.3 Japan Nanoparticles in Biotechnology and Pharmaceuticals Sales and Growth Rate (2013-2018)

7.4 Korea Nanoparticles in Biotechnology and Pharmaceuticals Sales and Growth Rate (2013-2018)

7.5 India Nanoparticles in Biotechnology and Pharmaceuticals Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Nanoparticles in Biotechnology and Pharmaceuticals Sales and Growth Rate (2013-2018)

8 South America Nanoparticles in Biotechnology and Pharmaceuticals by Countries

8.1 South America Nanoparticles in Biotechnology and Pharmaceuticals Sales, Revenue and Market Share by Countries

8.1.1 South America Nanoparticles in Biotechnology and Pharmaceuticals Sales and Market Share by Countries (2013-2018)

8.1.2 South America Nanoparticles in Biotechnology and Pharmaceuticals Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Nanoparticles in Biotechnology and Pharmaceuticals Sales and Growth Rate (2013-2018)

8.3 Argentina Nanoparticles in Biotechnology and Pharmaceuticals Sales and Growth Rate (2013-2018)

8.4 Colombia Nanoparticles in Biotechnology and Pharmaceuticals Sales and Growth Rate (2013-2018)

9 Middle East and Africa Nanoparticles in Biotechnology and Pharmaceuticals by Countries

9.1 Middle East and Africa Nanoparticles in Biotechnology and Pharmaceuticals Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Nanoparticles in Biotechnology and Pharmaceuticals Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Nanoparticles in Biotechnology and Pharmaceuticals Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Nanoparticles in Biotechnology and Pharmaceuticals Sales and Growth Rate (2013-2018)

9.3 UAE Nanoparticles in Biotechnology and Pharmaceuticals Sales and Growth Rate (2013-2018)

9.4 Egypt Nanoparticles in Biotechnology and Pharmaceuticals Sales and Growth Rate (2013-2018)

9.5 Nigeria Nanoparticles in Biotechnology and Pharmaceuticals Sales and Growth Rate (2013-2018)

9.6 South Africa Nanoparticles in Biotechnology and Pharmaceuticals Sales and Growth Rate (2013-2018)

10 Global Nanoparticles in Biotechnology and Pharmaceuticals Market Segment by Type

10.1 Global Nanoparticles in Biotechnology and Pharmaceuticals Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Nanoparticles in Biotechnology and Pharmaceuticals Sales and Market Share by Type (2013-2018)

10.1.2 Global Nanoparticles in Biotechnology and Pharmaceuticals Revenue and Market Share by Type (2013-2018)

10.2 Fullerenes Sales Growth and Price

10.2.1 Global Fullerenes Sales Growth (2013-2018)

10.2.2 Global Fullerenes Price (2013-2018)

10.3 Liquid Crystals Sales Growth and Price

10.3.1 Global Liquid Crystals Sales Growth (2013-2018)

10.3.2 Global Liquid Crystals Price (2013-2018)

10.4 Liposomes Sales Growth and Price

10.4.1 Global Liposomes Sales Growth (2013-2018)

10.4.2 Global Liposomes Price (2013-2018)

10.5 Nanoshells Sales Growth and Price

10.5.1 Global Nanoshells Sales Growth (2013-2018)

10.5.2 Global Nanoshells Price (2013-2018)

10.6 Quantum dots Sales Growth and Price

10.6.1 Global Quantum dots Sales Growth (2013-2018)

10.6.2 Global Quantum dots Price (2013-2018)

10.7 Superparamagnetic nanoparticles Sales Growth and Price

10.7.1 Global Superparamagnetic nanoparticles Sales Growth (2013-2018)

10.7.2 Global Superparamagnetic nanoparticles Price (2013-2018)

11 Global Nanoparticles in Biotechnology and Pharmaceuticals Market Segment by Application

11.1 Global Nanoparticles in Biotechnology and Pharmaceuticals Sales Market Share by Application (2013-2018)

11.2 Biotechnology Sales Growth (2013-2018)

11.3 Pharmaceutical Sales Growth (2013-2018)

12 Nanoparticles in Biotechnology and Pharmaceuticals Market Forecast (2018-2023)

12.1 Global Nanoparticles in Biotechnology and Pharmaceuticals Sales, Revenue and Growth Rate (2018-2023)

12.2 Nanoparticles in Biotechnology and Pharmaceuticals Market Forecast by Regions (2018-2023)

12.2.1 North America Nanoparticles in Biotechnology and Pharmaceuticals Market Forecast (2018-2023)

12.2.2 Europe Nanoparticles in Biotechnology and Pharmaceuticals Market Forecast (2018-2023)

12.2.3 Asia-Pacific Nanoparticles in Biotechnology and Pharmaceuticals Market Forecast (2018-2023)

12.2.4 South America Nanoparticles in Biotechnology and Pharmaceuticals Market Forecast (2018-2023)

12.2.5 Middle East and Africa Nanoparticles in Biotechnology and Pharmaceuticals Market Forecast (2018-2023)

12.3 Nanoparticles in Biotechnology and Pharmaceuticals Market Forecast by Type (2018-2023)

12.3.1 Global Nanoparticles in Biotechnology and Pharmaceuticals Sales Forecast by Type (2018-2023)

12.3.2 Global Nanoparticles in Biotechnology and Pharmaceuticals Market Share Forecast by Type (2018-2023)

12.4 Nanoparticles in Biotechnology and Pharmaceuticals Market Forecast by Application (2018-2023)

12.4.1 Global Nanoparticles in Biotechnology and Pharmaceuticals Sales Forecast by Application (2018-2023)

12.4.2 Global Nanoparticles in Biotechnology and Pharmaceuticals Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures



Figure Nanoparticles in Biotechnology and Pharmaceuticals Picture

Table Product Specifications of Nanoparticles in Biotechnology and Pharmaceuticals

Figure Global Sales Market Share of Nanoparticles in Biotechnology and Pharmaceuticals by Types in 2017

Table Nanoparticles in Biotechnology and Pharmaceuticals Types for Major Manufacturers

Figure Fullerenes Picture

Figure Liquid Crystals Picture

Figure Liposomes Picture

Figure Nanoshells Picture

Figure Quantum dots Picture

Figure Superparamagnetic nanoparticles Picture

Figure Nanoparticles in Biotechnology and Pharmaceuticals Sales Market Share by Applications in 2017

Figure Biotechnology Picture

Figure Pharmaceutical Picture

Figure United States Nanoparticles in Biotechnology and Pharmaceuticals Revenue (Value) and Growth Rate (2013-2023)

Figure Canada Nanoparticles in Biotechnology and Pharmaceuticals Revenue (Value) and Growth Rate (2013-2023)

Figure Mexico Nanoparticles in Biotechnology and Pharmaceuticals Revenue (Value) and Growth Rate (2013-2023)

Figure Germany Nanoparticles in Biotechnology and Pharmaceuticals Revenue (Value) and Growth Rate (2013-2023)

Figure France Nanoparticles in Biotechnology and Pharmaceuticals Revenue (Value) and Growth Rate (2013-2023)

Figure UK Nanoparticles in Biotechnology and Pharmaceuticals Revenue (Value) and Growth Rate (2013-2023)

Figure Russia Nanoparticles in Biotechnology and Pharmaceuticals Revenue (Value) and Growth Rate (2013-2023)

Figure Italy Nanoparticles in Biotechnology and Pharmaceuticals Revenue (Value) and Growth Rate (2013-2023)

Figure China Nanoparticles in Biotechnology and Pharmaceuticals Revenue (Value) and Growth Rate (2013-2023)

Figure Japan Nanoparticles in Biotechnology and Pharmaceuticals Revenue (Value) and Growth Rate (2013-2023)

Figure Korea Nanoparticles in Biotechnology and Pharmaceuticals Revenue (Value) and Growth Rate (2013-2023)

Figure India Nanoparticles in Biotechnology and Pharmaceuticals Revenue (Value) and Growth Rate (2013-2023)

Figure Southeast Asia Nanoparticles in Biotechnology and Pharmaceuticals Revenue (Value) and Growth Rate (2013-2023)

Figure Brazil Nanoparticles in Biotechnology and Pharmaceuticals Revenue (Value) and Growth Rate (2013-2023)

Figure Egypt Nanoparticles in Biotechnology and Pharmaceuticals Revenue (Value) and Growth Rate (2013-2023)

Figure Saudi Arabia Nanoparticles in Biotechnology and Pharmaceuticals Revenue (Value) and Growth Rate (2013-2023)

Figure South Africa Nanoparticles in Biotechnology and Pharmaceuticals Revenue (Value) and Growth Rate (2013-2023)

Figure Nigeria Nanoparticles in Biotechnology and Pharmaceuticals Revenue (Value) and Growth Rate (2013-2023)

Table Roche Basic Information, Manufacturing Base and Competitors

Table Roche Nanoparticles in Biotechnology and Pharmaceuticals Type and Applications

Table Roche Nanoparticles in Biotechnology and Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table GE Healthcare Basic Information, Manufacturing Base and Competitors

Table GE Healthcare Nanoparticles in Biotechnology and Pharmaceuticals Type and Applications

Table GE Healthcare Nanoparticles in Biotechnology and Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Merck Basic Information, Manufacturing Base and Competitors

Table Merck Nanoparticles in Biotechnology and Pharmaceuticals Type and Applications

Table Merck Nanoparticles in Biotechnology and Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Novartis Basic Information, Manufacturing Base and Competitors

Table Novartis Nanoparticles in Biotechnology and Pharmaceuticals Type and Applications

Table Novartis Nanoparticles in Biotechnology and Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table AMAG Pharmaceuticals Basic Information, Manufacturing Base and Competitors

Table AMAG Pharmaceuticals Nanoparticles in Biotechnology and Pharmaceuticals Type and Applications

Table AMAG Pharmaceuticals Nanoparticles in Biotechnology and Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Amgen Basic Information, Manufacturing Base and Competitors

Table Amgen Nanoparticles in Biotechnology and Pharmaceuticals Type and Applications

Table Amgen Nanoparticles in Biotechnology and Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Bausch & Lomb Basic Information, Manufacturing Base and Competitors

Table Bausch & Lomb Nanoparticles in Biotechnology and Pharmaceuticals Type and Applications

Table Bausch & Lomb Nanoparticles in Biotechnology and Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Biogen Basic Information, Manufacturing Base and Competitors

Table Biogen Nanoparticles in Biotechnology and Pharmaceuticals Type and Applications

Table Biogen Nanoparticles in Biotechnology and Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Celgene Basic Information, Manufacturing Base and Competitors

Table Celgene Nanoparticles in Biotechnology and Pharmaceuticals Type and Applications

Table Celgene Nanoparticles in Biotechnology and Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Gilead Basic Information, Manufacturing Base and Competitors

Table Gilead Nanoparticles in Biotechnology and Pharmaceuticals Type and Applications

Table Gilead Nanoparticles in Biotechnology and Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Ipsen Basic Information, Manufacturing Base and Competitors

Table Ipsen Nanoparticles in Biotechnology and Pharmaceuticals Type and Applications

Table Ipsen Nanoparticles in Biotechnology and Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Leadiant Biosciences Basic Information, Manufacturing Base and Competitors

Table Leadiant Biosciences Nanoparticles in Biotechnology and Pharmaceuticals Type and Applications

Table Leadiant Biosciences Nanoparticles in Biotechnology and Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table nanoComposix Basic Information, Manufacturing Base and Competitors

Table nanoComposix Nanoparticles in Biotechnology and Pharmaceuticals Type and Applications

Table nanoComposix Nanoparticles in Biotechnology and Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Pacira Pharmaceuticals Basic Information, Manufacturing Base and Competitors

Table Pacira Pharmaceuticals Nanoparticles in Biotechnology and Pharmaceuticals Type and Applications

Table Pacira Pharmaceuticals Nanoparticles in Biotechnology and Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Pfizer Basic Information, Manufacturing Base and Competitors

Table Pfizer Nanoparticles in Biotechnology and Pharmaceuticals Type and Applications

Table Pfizer Nanoparticles in Biotechnology and Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Shire Basic Information, Manufacturing Base and Competitors

Table Shire Nanoparticles in Biotechnology and Pharmaceuticals Type and Applications

Table Shire Nanoparticles in Biotechnology and Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Global Nanoparticles in Biotechnology and Pharmaceuticals Sales by Manufacturer (2016-2017)

Figure Global Nanoparticles in Biotechnology and Pharmaceuticals Sales Market Share by Manufacturer in 2016

Figure Global Nanoparticles in Biotechnology and Pharmaceuticals Sales Market Share by Manufacturer in 2017

Table Global Nanoparticles in Biotechnology and Pharmaceuticals Revenue by Manufacturer (2016-2017)

Figure Global Nanoparticles in Biotechnology and Pharmaceuticals Revenue Market Share by Manufacturer in 2016

Figure Global Nanoparticles in Biotechnology and Pharmaceuticals Revenue Market Share by Manufacturer in 2017

Figure Top 3 Nanoparticles in Biotechnology and Pharmaceuticals Manufacturer (Revenue) Market Share in 2017

Figure Top 6 Nanoparticles in Biotechnology and Pharmaceuticals Manufacturer (Revenue) Market Share in 2017

Figure Global Nanoparticles in Biotechnology and Pharmaceuticals Sales and Growth Rate (2013-2018)

Figure Global Nanoparticles in Biotechnology and Pharmaceuticals Revenue and Growth Rate (2013-2018)

Table Global Nanoparticles in Biotechnology and Pharmaceuticals Sales by Regions (2013-2018)

Table Global Nanoparticles in Biotechnology and Pharmaceuticals Sales Market Share by Regions (2013-2018)

Table Global Nanoparticles in Biotechnology and Pharmaceuticals Revenue by Regions (2013-2018)

Figure Global Nanoparticles in Biotechnology and Pharmaceuticals Revenue Market Share by Regions in 2013

Figure Global Nanoparticles in Biotechnology and Pharmaceuticals Revenue Market Share by Regions in 2017

Figure North America Nanoparticles in Biotechnology and Pharmaceuticals Sales and Growth Rate (2013-2018)

Figure Europe Nanoparticles in Biotechnology and Pharmaceuticals Sales and Growth Rate (2013-2018)

Figure Asia-Pacific Nanoparticles in Biotechnology and Pharmaceuticals Sales and Growth Rate (2013-2018)

Figure South America Nanoparticles in Biotechnology and Pharmaceuticals Sales and Growth Rate (2013-2018)

Figure Middle East and Africa Nanoparticles in Biotechnology and Pharmaceuticals Sales and Growth Rate (2013-2018)

Figure North America Nanoparticles in Biotechnology and Pharmaceuticals Revenue and Growth Rate (2013-2018)

Table North America Nanoparticles in Biotechnology and Pharmaceuticals Sales by Countries (2013-2018)

Table North America Nanoparticles in Biotechnology and Pharmaceuticals Sales Market Share by Countries (2013-2018)

Figure North America Nanoparticles in Biotechnology and Pharmaceuticals Sales Market Share by Countries in 2013

Figure North America Nanoparticles in Biotechnology and Pharmaceuticals Sales Market Share by Countries in 2017

Table North America Nanoparticles in Biotechnology and Pharmaceuticals Revenue by Countries (2013-2018)

Table North America Nanoparticles in Biotechnology and Pharmaceuticals Revenue Market Share by Countries (2013-2018)

Figure North America Nanoparticles in Biotechnology and Pharmaceuticals Revenue Market Share by Countries in 2013

Figure North America Nanoparticles in Biotechnology and Pharmaceuticals Revenue Market Share by Countries in 2017

Figure United States Nanoparticles in Biotechnology and Pharmaceuticals Sales and Growth Rate (2013-2018)

Figure Canada Nanoparticles in Biotechnology and Pharmaceuticals Sales and Growth Rate (2013-2018)

Figure Mexico Nanoparticles in Biotechnology and Pharmaceuticals Sales and Growth Rate (2013-2018)

Figure Europe Nanoparticles in Biotechnology and Pharmaceuticals Revenue and Growth Rate (2013-2018)

Table Europe Nanoparticles in Biotechnology and Pharmaceuticals Sales by Countries (2013-2018)

Table Europe Nanoparticles in Biotechnology and Pharmaceuticals Sales Market Share by Countries (2013-2018)

Table Europe Nanoparticles in Biotechnology and Pharmaceuticals Revenue by Countries (2013-2018)

Figure Europe Nanoparticles in Biotechnology and Pharmaceuticals Revenue Market Share by Countries in 2016

Figure Europe Nanoparticles in Biotechnology and Pharmaceuticals Revenue Market Share by Countries in 2017

Figure Germany Nanoparticles in Biotechnology and Pharmaceuticals Sales and Growth Rate (2013-2018)

Figure UK Nanoparticles in Biotechnology and Pharmaceuticals Sales and Growth Rate (2013-2018)

Figure France Nanoparticles in Biotechnology and Pharmaceuticals Sales and Growth Rate (2013-2018)

Figure Russia Nanoparticles in Biotechnology and Pharmaceuticals Sales and Growth Rate (2013-2018)

Figure Italy Nanoparticles in Biotechnology and Pharmaceuticals Sales and Growth Rate (2013-2018)

Figure Asia-Pacific Nanoparticles in Biotechnology and Pharmaceuticals Revenue and Growth Rate (2013-2018)

Table Asia-Pacific Nanoparticles in Biotechnology and Pharmaceuticals Sales by Countries (2013-2018)

Table Asia-Pacific Nanoparticles in Biotechnology and Pharmaceuticals Sales Market Share by Countries (2013-2018)

Figure Asia-Pacific Nanoparticles in Biotechnology and Pharmaceuticals Sales Market Share by Countries 2017

Table Asia-Pacific Nanoparticles in Biotechnology and Pharmaceuticals Revenue by Countries (2013-2018)

Figure Asia-Pacific Nanoparticles in Biotechnology and Pharmaceuticals Revenue Market Share by Countries 2017

Figure China Nanoparticles in Biotechnology and Pharmaceuticals Sales and Growth Rate (2013-2018)

Figure Japan Nanoparticles in Biotechnology and Pharmaceuticals Sales and Growth Rate (2013-2018)

Figure Korea Nanoparticles in Biotechnology and Pharmaceuticals Sales and Growth Rate (2013-2018)

Figure India Nanoparticles in Biotechnology and Pharmaceuticals Sales and Growth Rate (2013-2018)

Figure Southeast Asia Nanoparticles in Biotechnology and Pharmaceuticals Sales and Growth Rate (2013-2018)

Figure South America Nanoparticles in Biotechnology and Pharmaceuticals Revenue and Growth Rate (2013-2018)

Table South America Nanoparticles in Biotechnology and Pharmaceuticals Sales by Countries (2013-2018)

Table South America Nanoparticles in Biotechnology and Pharmaceuticals Sales Market Share by Countries (2013-2018)

Figure South America Nanoparticles in Biotechnology and Pharmaceuticals Sales Market Share by Countries in 2017

Table South America Nanoparticles in Biotechnology and Pharmaceuticals Revenue by Countries (2013-2018)

Table South America Nanoparticles in Biotechnology and Pharmaceuticals Revenue Market Share by Countries (2013-2018)

Figure South America Nanoparticles in Biotechnology and Pharmaceuticals Revenue Market Share by Countries in 2017

Figure Brazil Nanoparticles in Biotechnology and Pharmaceuticals Sales and Growth Rate (2013-2018)

Figure Argentina Nanoparticles in Biotechnology and Pharmaceuticals Sales and Growth Rate (2013-2018)

Figure Colombia Nanoparticles in Biotechnology and Pharmaceuticals Sales and Growth Rate (2013-2018)

Figure Middle East and Africa Nanoparticles in Biotechnology and Pharmaceuticals Revenue and Growth Rate (2013-2018)

Table Middle East and Africa Nanoparticles in Biotechnology and Pharmaceuticals Sales by Countries (2013-2018)

Table Middle East and Africa Nanoparticles in Biotechnology and Pharmaceuticals Sales Market Share by Countries (2013-2018)

Figure Middle East and Africa Nanoparticles in Biotechnology and Pharmaceuticals Sales Market Share by Countries in 2017

Table Middle East and Africa Nanoparticles in Biotechnology and Pharmaceuticals Revenue by Countries (2013-2018)

Table Middle East and Africa Nanoparticles in Biotechnology and Pharmaceuticals Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Nanoparticles in Biotechnology and Pharmaceuticals Revenue Market Share by Countries in 2013

Figure Middle East and Africa Nanoparticles in Biotechnology and Pharmaceuticals Revenue Market Share by Countries in 2017

Figure Saudi Arabia Nanoparticles in Biotechnology and Pharmaceuticals Sales and Growth Rate (2013-2018)

Figure UAE Nanoparticles in Biotechnology and Pharmaceuticals Sales and Growth Rate (2013-2018)

Figure Egypt Nanoparticles in Biotechnology and Pharmaceuticals Sales and Growth Rate (2013-2018)

Figure Nigeria Nanoparticles in Biotechnology and Pharmaceuticals Sales and Growth Rate (2013-2018)

Figure South Africa Nanoparticles in Biotechnology and Pharmaceuticals Sales and Growth Rate (2013-2018)

Table Global Nanoparticles in Biotechnology and Pharmaceuticals Sales by Type (2013-2018)

Table Global Nanoparticles in Biotechnology and Pharmaceuticals Sales Share by Type (2013-2018)

Table Global Nanoparticles in Biotechnology and Pharmaceuticals Revenue by Type (2013-2018)

Table Global Nanoparticles in Biotechnology and Pharmaceuticals Revenue Share by Type (2013-2018)

Figure Global Fullerenes Sales Growth (2013-2018)

Figure Global Fullerenes Price (2013-2018)

Figure Global Liquid Crystals Sales Growth (2013-2018)

Figure Global Liquid Crystals Price (2013-2018)

Figure Global Liposomes Sales Growth (2013-2018)

Figure Global Liposomes Price (2013-2018)

Figure Global Nanoshells Sales Growth (2013-2018)

Figure Global Nanoshells Price (2013-2018)

Figure Global Quantum dots Sales Growth (2013-2018)

Figure Global Quantum dots Price (2013-2018)

Figure Global Superparamagnetic nanoparticles Sales Growth (2013-2018)

Figure Global Superparamagnetic nanoparticles Price (2013-2018)

Table Global Nanoparticles in Biotechnology and Pharmaceuticals Sales by Application (2013-2018)

Table Global Nanoparticles in Biotechnology and Pharmaceuticals Sales Share by Application (2013-2018)

Figure Global Pharmaceutical Sales Growth (2013-2018)

Figure Global Nanoparticles in Biotechnology and Pharmaceuticals Sales, Revenue and Growth Rate (2018-2023)

Table Global Nanoparticles in Biotechnology and Pharmaceuticals Sales Forecast by Regions (2018-2023)

Table Global Nanoparticles in Biotechnology and Pharmaceuticals Market Share Forecast by Regions (2018-2023)

Figure North America Sales Nanoparticles in Biotechnology and Pharmaceuticals Market Forecast (2018-2023)

Figure Europe Sales Nanoparticles in Biotechnology and Pharmaceuticals Market Forecast (2018-2023)

Figure Asia-Pacific Sales Nanoparticles in Biotechnology and Pharmaceuticals Market Forecast (2018-2023)

Figure South America Sales Nanoparticles in Biotechnology and Pharmaceuticals Market Forecast (2018-2023)

Figure Middle East and Africa Sales Nanoparticles in Biotechnology and Pharmaceuticals Market Forecast (2018-2023)

Table Global Nanoparticles in Biotechnology and Pharmaceuticals Sales Forecast by Type (2018-2023)

Table Global Nanoparticles in Biotechnology and Pharmaceuticals Market Share Forecast by Type (2018-2023)

Table Global Nanoparticles in Biotechnology and Pharmaceuticals Sales Forecast by Application (2018-2023)

Table Global Nanoparticles in Biotechnology and Pharmaceuticals Market Share Forecast by Application (2018-2023)

Table Distributors/Traders/ Dealers List



【レポートのキーワード】

バイオテクノロジーおよび医薬品におけるナノ粒子、フラーレン類、液晶、リポソーム、ナノシェル、量子ドット、その他、バイオテクノロジー、医薬品

★調査レポート[バイオテクノロジーおよび医薬品におけるナノ粒子の世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2023)] (コード:GIR8104396)販売に関する免責事項を必ずご確認ください。
★調査レポート[バイオテクノロジーおよび医薬品におけるナノ粒子の世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2023)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆